$AGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Allergan plc. Get notifications about new insider transactions in Allergan plc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | D | 70.79 | 2,619 | 185,399 | 0 | |
May 12 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | D | 73.14 | 3,691 | 269,960 | 0 | |
May 12 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | D | 90.22 | 2,790 | 251,714 | 0 | |
May 12 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | D | 0.00 | 6,889 | 0 | 0 | 6.9 K to 0 (-100.00 %) |
May 12 2020 | AGN | Allergan plc | Boccuzi Joseph H | Director | Sell | D | 0.00 | 3,605 | 0 | 0 | 3.6 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | HUGIN ROBERT J | Director | Sell | D | 0.00 | 4,294 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | HUGIN ROBERT J | Director | Sell | D | 0.00 | 4,294 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | BODINE CHRIS W | Director | Sell | D | 0.00 | 18,615 | 0 | 0 | 18.6 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | BODINE CHRIS W | Director | Sell | D | 0.00 | 18,615 | 0 | 0 | 18.6 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Option Exercise | D | 0.00 | 3,534 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Option Exercise | D | 0.00 | 3,534 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Option Exercise | D | 224.00 | 4,957 | 1,110,368 | 0 | |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Option Exercise | D | 224.00 | 4,957 | 1,110,368 | 0 | |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Option Exercise | D | 296.14 | 1,169 | 346,188 | 0 | |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Option Exercise | D | 296.14 | 1,169 | 346,188 | 0 | |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Sell | D | 0.00 | 6,324 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Sell | D | 0.00 | 6,324 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Sell | D | 0.00 | 3,511 | 0 | 0 | 3.5 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Sell | D | 0.00 | 3,511 | 0 | 0 | 3.5 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Brown Adriane M | Director | Sell | D | 0.00 | 2,916 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Brown Adriane M | Director | Sell | D | 0.00 | 2,916 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 0.00 | 17,670 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 0.00 | 17,670 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 196.16 | 12,304 | 2,413,553 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 196.16 | 12,304 | 2,413,553 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 103.79 | 9,750 | 1,011,953 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 103.79 | 9,750 | 1,011,953 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 196.16 | 509 | 99,845 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 196.16 | 509 | 99,845 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 103.79 | 3,852 | 399,799 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 103.79 | 3,852 | 399,799 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 224.00 | 16,524 | 3,701,376 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Option Exercise | D | 224.00 | 16,524 | 3,701,376 | 0 | |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Sell | D | 0.00 | 16,800 | 0 | 0 | 16.8 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Sell | D | 0.00 | 16,800 | 0 | 0 | 16.8 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Sell | D | 0.00 | 17,629 | 0 | 0 | 17.6 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Sell | D | 0.00 | 17,629 | 0 | 0 | 17.6 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Sell | D | 0.00 | 2,983 | 0 | 0 | 3 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Sell | D | 0.00 | 2,983 | 0 | 0 | 3 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Option Exercise | D | 0.00 | 28,021 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Option Exercise | D | 0.00 | 28,021 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Sell | D | 0.00 | 27,618 | 0 | 0 | 27.6 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Sell | D | 0.00 | 27,618 | 0 | 0 | 27.6 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Sell | D | 0.00 | 12,039 | 0 | 0 | 12 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Sell | D | 0.00 | 12,039 | 0 | 0 | 12 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | DAVIDSON CAROL ANTHONY | Director | Sell | D | 0.00 | 2,105 | 0 | 0 | 2.1 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | DAVIDSON CAROL ANTHONY | Director | Sell | D | 0.00 | 2,105 | 0 | 0 | 2.1 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Option Exercise | D | 0.00 | 12,129 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Option Exercise | D | 0.00 | 12,129 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Option Exercise | D | 307.51 | 1,369 | 420,981 | 0 | |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Option Exercise | D | 307.51 | 1,369 | 420,981 | 0 | |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Option Exercise | D | 224.00 | 5,508 | 1,233,792 | 0 | |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Option Exercise | D | 224.00 | 5,508 | 1,233,792 | 0 | |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Sell | D | 0.00 | 12,050 | 0 | 0 | 12.1 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Sell | D | 0.00 | 12,050 | 0 | 0 | 12.1 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Sell | D | 0.00 | 8,915 | 0 | 0 | 8.9 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Sell | D | 0.00 | 8,915 | 0 | 0 | 8.9 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Option Exercise | D | 0.00 | 26,506 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Option Exercise | D | 0.00 | 26,506 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Option Exercise | D | 215.77 | 17,006 | 3,669,385 | 0 | |
May 11 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Option Exercise | D | 215.77 | 17,006 | 3,669,385 | 0 | |
May 11 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Sell | D | 0.00 | 25,201 | 0 | 0 | 25.2 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Sell | D | 0.00 | 25,201 | 0 | 0 | 25.2 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Sell | D | 0.00 | 9,999 | 0 | 0 | 10 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Sell | D | 0.00 | 9,999 | 0 | 0 | 10 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Greenberg Michael Eldon | Director | Sell | D | 0.00 | 1,693 | 0 | 0 | 1.7 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Greenberg Michael Eldon | Director | Sell | D | 0.00 | 1,693 | 0 | 0 | 1.7 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 0.00 | 26,506 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 0.00 | 26,506 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 196.16 | 12,304 | 2,413,553 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 196.16 | 12,304 | 2,413,553 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 80.20 | 21,621 | 1,734,004 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 80.20 | 21,621 | 1,734,004 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 72.07 | 10,089 | 727,114 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 72.07 | 10,089 | 727,114 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 63.51 | 16,081 | 1,021,304 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 63.51 | 16,081 | 1,021,304 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 196.16 | 509 | 99,845 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 196.16 | 509 | 99,845 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 80.20 | 1,246 | 99,929 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 80.20 | 1,246 | 99,929 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 72.07 | 1,387 | 99,961 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 72.07 | 1,387 | 99,961 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 63.51 | 1 | 64 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 63.51 | 1 | 64 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 224.00 | 19,278 | 4,318,272 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Option Exercise | D | 224.00 | 19,278 | 4,318,272 | 0 | |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Sell | D | 0.00 | 25,201 | 0 | 0 | 25.2 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Sell | D | 0.00 | 25,201 | 0 | 0 | 25.2 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Sell | D | 0.00 | 7,434 | 0 | 0 | 7.4 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Sell | D | 0.00 | 7,434 | 0 | 0 | 7.4 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | McDonnell Peter J | Director | Sell | D | 0.00 | 6,352 | 0 | 0 | 6.4 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | McDonnell Peter J | Director | Sell | D | 0.00 | 6,352 | 0 | 0 | 6.4 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 0.00 | 83,936 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 0.00 | 83,936 | 0 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 196.16 | 1 | 196 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 196.16 | 1 | 196 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 196.16 | 62,547 | 12,269,220 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 196.16 | 62,547 | 12,269,220 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 91.13 | 219,667 | 20,018,254 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 91.13 | 219,667 | 20,018,254 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 90.22 | 2,790 | 251,714 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 90.22 | 2,790 | 251,714 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 73.14 | 3,691 | 269,960 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 73.14 | 3,691 | 269,960 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 70.79 | 9,446 | 668,682 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 70.79 | 9,446 | 668,682 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 196.16 | 1,018 | 199,691 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 196.16 | 1,018 | 199,691 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 91.13 | 3,291 | 299,909 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 91.13 | 3,291 | 299,909 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 224.00 | 104,651 | 23,441,824 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | D | 224.00 | 104,651 | 23,441,824 | 0 | |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Sell | D | 0.00 | 79,805 | 0 | 0 | 79.8 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Sell | D | 0.00 | 79,805 | 0 | 0 | 79.8 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Sell | D | 0.00 | 149,384 | 0 | 0 | 149.4 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Sell | D | 0.00 | 149,384 | 0 | 0 | 149.4 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 70.79 | 9,446 | 668,682 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 70.79 | 9,446 | 668,682 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 73.14 | 3,691 | 269,960 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 73.14 | 3,691 | 269,960 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 90.22 | 2,790 | 251,714 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Option Exercise | D | 90.22 | 2,790 | 251,714 | 0 | |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 16,532 | 0 | 0 | 16.5 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 16,532 | 0 | 0 | 16.5 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 9,538 | 0 | 16,542 | 26.1 K to 16.5 K (-36.57 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 9,538 | 0 | 16,542 | 26.1 K to 16.5 K (-36.57 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 471 | 0 | 26,080 | 26.6 K to 26.1 K (-1.77 %) |
May 11 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Sell | D | 0.00 | 471 | 0 | 26,080 | 26.6 K to 26.1 K (-1.77 %) |
May 04 2020 | AGN | Allergan plc | DAVIDSON CAROL ANTHONY | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 2,105 | 3.1 K to 2.1 K (-32.01 %) |
May 04 2020 | AGN | Allergan plc | Brown Adriane M | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 2,916 | 3.9 K to 2.9 K (-25.36 %) |
May 04 2020 | AGN | Allergan plc | Greenberg Michael Eldon | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 1,693 | 2.7 K to 1.7 K (-36.92 %) |
May 04 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 189.74 | 2,064 | 391,623 | 2,983 | 5 K to 3 K (-40.90 %) |
May 04 2020 | AGN | Allergan plc | Boccuzi Joseph H | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 3,605 | 4.6 K to 3.6 K (-21.56 %) |
May 04 2020 | AGN | Allergan plc | BODINE CHRIS W | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 18,615 | 19.6 K to 18.6 K (-5.05 %) |
May 04 2020 | AGN | Allergan plc | HUGIN ROBERT J | Director | Payment of Exercise | F | 189.74 | 2,064 | 391,623 | 4,294 | 6.4 K to 4.3 K (-32.46 %) |
May 04 2020 | AGN | Allergan plc | McDonnell Peter J | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 6,352 | 7.3 K to 6.4 K (-13.50 %) |
May 04 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 6,889 | 7.9 K to 6.9 K (-12.58 %) |
May 04 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 280 | 0 | 7,880 | 8.2 K to 7.9 K (-3.43 %) |
May 04 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 6,889 | 7.9 K to 6.9 K (-12.58 %) |
May 04 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 280 | 0 | 7,880 | 8.2 K to 7.9 K (-3.43 %) |
May 04 2020 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 16,542 | 17.5 K to 16.5 K (-5.65 %) |
Apr 07 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Grant | A | 193.84 | 21,667 | 4,199,931 | 35,972 | 14.3 K to 36 K (+151.46 %) |
Apr 07 2020 | AGN | Allergan plc | Meury William | EVP & Chief Commerc ... | Payment of Exercise | F | 175.71 | 855 | 150,232 | 32,635 | 33.5 K to 32.6 K (-2.55 %) |
Apr 07 2020 | AGN | Allergan plc | Bailey A Robert D | EVP Chief Legal Off ... | Payment of Exercise | F | 175.71 | 581 | 102,088 | 34,427 | 35 K to 34.4 K (-1.66 %) |
Mar 10 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Payment of Exercise | F | 191.95 | 199 | 38,198 | 20,965 | 21.2 K to 21 K (-0.94 %) |
Mar 10 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Payment of Exercise | F | 191.95 | 718 | 137,820 | 9,834 | 10.6 K to 9.8 K (-6.80 %) |
Mar 04 2020 | AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Offic ... | Grant | A | 193.84 | 21,667 | 4,199,931 | 35,972 | 14.3 K to 36 K (+151.46 %) |
Mar 04 2020 | AGN | Allergan plc | Swanton Wayne R | EVP, Global Operati ... | Grant | A | 193.84 | 8,770 | 1,699,977 | 21,164 | 12.4 K to 21.2 K (+70.76 %) |
Mar 04 2020 | AGN | Allergan plc | DArecca James | SVP Chief Accountin ... | Grant | A | 193.84 | 3,611 | 699,956 | 10,552 | 6.9 K to 10.6 K (+52.02 %) |